2-(2-phenylethoxy)ethyl methanesulfonate | 81228-17-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(2-phenylethoxy)ethyl methanesulfonate
• 英文别名: 2-Phenethyloxy-ethanol mesylate
• CAS: 81228-17-3
• 化学式: C₁₁H₁₆O₄S
• 分子量: 244.312
• InChiKey: OKWMQTGEFGEVEH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  16
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  61
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(2-phenylethoxy)ethyl methanesulfonate 在 sodium methylate 、 sodium hydride 、 间氯过氧苯甲酸 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 121.75h， 生成 4-<2-<(2-phenylethyl)oxy>ethoxy>-2-cresol
  参考文献：
  名称：

  .beta.1-Selective adrenoceptor antagonists. 2. 4-Ether-linked phenoxypropanolamines

  摘要：

  A series of 4-substituted phenoxypropanolamines was prepared and examined for beta-adrenoceptor activity. Some of the compounds, especially the [4-[2-[[2-(4-fluorophenyl)ethyl] oxy]ethoxy]phenoxy]propanolamines (14, 15, and 24), showed potent beta 1-blockade with virtually no beta 2-blockade at doses over a 1000 times greater. The compounds also possessed partial agonist activity. Structure-activity relationships are discussed, and conclusions are drawn about the binding sites on beta-adrenoceptors.

  DOI：

  10.1021/jm00365a005
• 作为产物：
  描述：

  2-phenethyloxyacetic acid 在 吡啶 、 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 2-(2-phenylethoxy)ethyl methanesulfonate
  参考文献：
  名称：

  .beta.1-Selective adrenoceptor antagonists. 2. 4-Ether-linked phenoxypropanolamines

  摘要：

  A series of 4-substituted phenoxypropanolamines was prepared and examined for beta-adrenoceptor activity. Some of the compounds, especially the [4-[2-[[2-(4-fluorophenyl)ethyl] oxy]ethoxy]phenoxy]propanolamines (14, 15, and 24), showed potent beta 1-blockade with virtually no beta 2-blockade at doses over a 1000 times greater. The compounds also possessed partial agonist activity. Structure-activity relationships are discussed, and conclusions are drawn about the binding sites on beta-adrenoceptors.

  DOI：

  10.1021/jm00365a005

文献信息

• Generation of Alkoxyl Radicals by Photoredox Catalysis Enables Selective C(sp³ )−H Functionalization under Mild Reaction Conditions
  作者：Jing Zhang、Yang Li、Fuyuan Zhang、Chenchen Hu、Yiyun Chen

  DOI：10.1002/anie.201510014

  日期：2016.1.26

  Reported herein is the first visible‐light‐induced formation of alkoxyl radicals from N‐alkoxyphthalimides, and the Hantzsch ester as the reductant is crucial for the reaction. The selective hydrogen atom abstraction by the alkoxyl radical enables C(sp3)−H allylation and alkenylation reactions under mild reaction conditions at room temperature. Broad substrate variations, including a structurally complexed

  本文报道的是由N-烷氧基邻苯二甲酰亚胺形成的第一个可见光诱导的烷氧基自由基，汉茨酯作为还原剂对反应至关重要。烷氧基自由基对氢原子的选择性提取使C（sp 3）-H烯丙基化和烯基化反应在室温下温和的反应条件下进行。广泛的底物变化，包括结构复杂的类固醇，均能有效进行C（sp 3）-H官能化反应，并具有较高的区域选择性和化学选择性。
• Substituted phenoxy-aminopropanols
  申请人：Hoffmann-La Roche Inc.

  公开号：US04649160A1

  公开（公告）日：1987-03-10

  Substituted phenoxy-aminopropanols of the formula ##STR1## wherein R is a branched-chain alkyl of 3 or 4 carbon atoms, R.sup.1 is hydrogen, halogen or lower alkyl and R.sup.2 and R.sup.3, independently, are hydrogen, halogen, lower alkyl, lower alkoxy or lower alkylthio, and pharmaceutically acceptable acid addition salts thereof, are described. A process for their preparation, as well as pharmaceutical preparations containing them are also described. The compounds of formula I and their salts possess cardioselective .beta.-adrenergic blocking activity and antihypertensive activity.

  描述了式子##STR1##中R为3或4个碳原子的支链烷基，R.sup.1为氢、卤素或较低烷基，R.sup.2和R.sup.3独立地为氢、卤素、较低烷基、较低烷氧基或较低烷基硫基的苯氧基氨基丙醇衍生物，以及其药学上可接受的酸盐。还描述了一种制备它们的方法，以及含有它们的药物制剂。式I的化合物及其盐具有心脏选择性β-肾上腺素能受体阻滞活性和降压活性。
• Methods of treating alzheimer's disease
  申请人：Nieman A. James

  公开号：US20060079533A1

  公开（公告）日：2006-04-13

  Disclosed are methods for treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of 3,4-disubstituted piperidinyl compounds of formula (I) wherein the variables R 1 , R 2 , R 3 , R 4 , Q, W, X, Z, m, and n are defined herein.

  本发明公开了一种治疗阿尔茨海默病和其他疾病、抑制β-分泌酶酶和/或抑制哺乳动物中A beta肽沉积的方法，使用式(I)的3,4-二取代哌啶基化合物，其中变量R1、R2、R3、R4、Q、W、X、Z、m和n在此定义。
• Piperidine derivatives having renin inhibiting activity
  申请人：Hoffmann-La Roche Inc.

  公开号：US06051712A1

  公开（公告）日：2000-04-18

  Novel piperidine derivatives, their manufacture and use as medicaments, are disclosed. The invention is concerned with the novel piperidine derivatives of general formula I ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, Q, X, Z, m and n are as described herein.

  本发明涉及新型哌啶衍生物的制备和用作药物。本发明涉及一般式I的新型哌啶衍生物，其中R.sup.1，R.sup.2，R.sup.3，R.sup.4，Q，X，Z，m和n如本文所述。
• Piperidine derivative having renin inhibiting activity
  申请人：Hoffmann-La Roche Inc.

  公开号：US06150526A1

  公开（公告）日：2000-11-21

  Piperidine derivatives, their manufacture and use as medicaments, are disclosed. The invention is concerned with the piperidine derivatives of general formula I ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, Q, X, Z, m and n are as described herein.

  本发明涉及哌啶衍生物的制备和用作药物。该发明涉及一般式I的哌啶衍生物，其中R.sup.1，R.sup.2，R.sup.3，R.sup.4，Q，X，Z，m和n如本文所述。